Skip to main content
Daily Report

Daily Ards Research Analysis

11/22/2025
3 papers selected
3 analyzed

Across ARDS-related research, a large PRISMA-compliant systematic review consolidates mechanical power as a consistent predictor of ventilator-related harm with reproducible thresholds. A prospective physiologic study shows that inhaled nitric oxide and prone positioning each improve V/Q matching but lack synergistic benefit, while a multidisciplinary physiology-guided Lung Rescue Team demonstrates actionable management changes and non-negligible survival in patients ineligible for ECMO.

Summary

Across ARDS-related research, a large PRISMA-compliant systematic review consolidates mechanical power as a consistent predictor of ventilator-related harm with reproducible thresholds. A prospective physiologic study shows that inhaled nitric oxide and prone positioning each improve V/Q matching but lack synergistic benefit, while a multidisciplinary physiology-guided Lung Rescue Team demonstrates actionable management changes and non-negligible survival in patients ineligible for ECMO.

Research Themes

  • Ventilation mechanics and VILI risk stratification
  • Physiology-guided individualized management in severe hypoxemia
  • Adjunctive therapies in ARDS (iNO, prone positioning) and their limits

Selected Articles

1. Mechanical power in mechanical ventilation and its association with ventilator-induced lung injury: A systematic review.

75.5Level IISystematic Review
Respiratory medicine · 2025PMID: 41270941

This PRISMA-guided systematic review of 46 studies (314,823 patients) shows a robust association between higher mechanical power and adverse outcomes, with reproducible thresholds around 14–18 J/min. Normalized mechanical power improved prognostic performance, supporting its integration alongside tidal volume and driving pressure in lung-protective strategies.

Impact: By synthesizing over 300,000 patients with rigorous bias assessment, this work anchors mechanical power as a clinically meaningful predictor and provides actionable thresholds for bedside risk titration.

Clinical Implications: Consider tracking mechanical power and aiming to keep it below ~14–18 J/min when feasible, and evaluate normalized MP to the patient's predicted body weight or well-aerated lung volume to refine lung-protective ventilation decisions.

Key Findings

  • Across 46 studies (314,823 patients), higher mechanical power consistently associated with mortality, prolonged ventilation, and longer ICU stay (87% of studies significant).
  • Threshold effects for mechanical power were reproducibly identified around 14–18 J/min in 23 studies.
  • Normalization of mechanical power (e.g., per predicted body weight or well-aerated lung volume) improved prognostic performance in selected cohorts.

Methodological Strengths

  • PRISMA-compliant systematic search across four databases with RoB 2.0 and ROBINS-I bias assessment and GRADE certainty rating
  • Large aggregated sample size enabling threshold exploration and subgroup consistency

Limitations

  • Predominantly observational evidence with clinical and methodological heterogeneity
  • Variability in mechanical power calculation and potential residual confounding/publication bias

Future Directions: Prospective, randomized or adaptive trials testing MP-guided ventilation targets, external validation of normalized MP metrics, and integration with imaging/EIT to individualize lung-protective settings.

BACKGROUND: Mechanical power (MP) quantifies the total energy delivered from the ventilator to the respiratory system per unit time, integrating tidal volume, airway pressures, respiratory rate, and flow. MP has been proposed as a surrogate marker of ventilator-induced lung injury (VILI), but the consistency and generalizability of this association across patient populations remain uncertain. OBJECTIVES: To provide the most comprehensive systematic evaluation to date of the relationship between MP and VILI-related outcomes in adult patients receiving invasive mechanical ventilation. METHODS: We conducted a systematic review following PRISMA guidelines. Four databases (PubMed, Embase, Scopus, Web of Science) were searched for original studies reporting MP and clinical outcomes related to VILI. Risk of bias was assessed using RoB 2.0 and ROBINS-I tools. Certainty of evidence was rated using the GRADE approach. RESULTS: Forty-six studies including 314,823 patients were analyzed. Forty (87 %) demonstrated a statistically significant association between higher MP and adverse outcomes (mortality, prolonged ventilation, or ICU stay). Threshold effects were identified in 23 studies, most consistently between 14 and 18 J/min. Normalized MP (e.g., per predicted body weight or well-aerated lung volume) improved prognostic performance in selected cohorts. Despite heterogeneity and mostly observational designs, the overall signal was robust across diverse populations and clinical contexts. CONCLUSIONS: This review establishes mechanical power as a consistent and clinically relevant predictor of adverse outcomes in mechanically ventilated adults. By synthesizing >300,000 patients, it provides the most reliable evidence base to date, identifies reproducible thresholds, and highlights the importance of normalization strategies. These findings suggest that MP could complement tidal volume and driving pressure in lung-protective ventilation and define priorities for future prospective trials.

2. Investigating the effect of inhaled nitric oxide combined with prone position ventilation on ventilation/perfusion matching in patients with moderate-to-severe acute respiratory distress syndrome.

63Level IIICohort
Nitric oxide : biology and chemistry · 2025PMID: 41271155

In a prospective 2×2 factorial physiologic study using EIT in 24 severe ARDS patients, both inhaled nitric oxide and prone positioning improved V/Q matching and oxygenation. However, their combination did not yield additive benefits, suggesting targeted rather than routine simultaneous use.

Impact: This study clarifies the physiologic effects and limits of combining two widely used adjuncts in ARDS and leverages EIT to quantify V/Q matching in vivo.

Clinical Implications: Use iNO or prone positioning based on individualized physiologic response; avoid assuming synergistic benefits from simultaneous application. EIT can guide selection and titration.

Key Findings

  • In 24 severe ARDS patients, iNO and prone positioning each improved V/Q matching and oxygenation.
  • No synergistic or additive effect was observed when combining iNO with prone positioning.
  • EIT-derived metrics (ventilation/perfusion GI indices, dead space, shunt) captured physiologic improvements under each intervention.

Methodological Strengths

  • Prospective 2×2 factorial repeated-measures design enabling within-patient comparisons
  • Objective EIT-based V/Q assessment alongside gas exchange, mechanics, and hemodynamics

Limitations

  • Small, single-center cohort with short-term physiologic endpoints
  • Lack of randomization and potentially limited generalizability

Future Directions: Randomized trials to test clinical outcome impacts of iNO versus prone sequencing, responder identification, dosing strategies, and EIT-guided protocols.

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by refractory hypoxemia resulting from ventilation-perfusion (V/Q) mismatch. Studies have shown that inhaled nitric oxide (iNO) and prone position (PP) ventilation may improve V/Q mismatch and oxygenation when used separately. Despite the known individual benefits of iNO and PP, few studies have investigated their potential synergistic effects. The aim of this study was to evaluate iNO combined with PP on V/Q matching and oxygenation in patients with moderate-to-severe ARDS. METHODS: A 2 × 2 factorial design was adopted in this study. Patients admitted to the Intensive Care Unit of Northern Jiangsu People's Hospital from January 2024 to December 2024, who met the diagnostic criteria for moderate-to-severe ARDS (aged 18-80 years, oxygenation index <150 mmHg, and requiring mechanical ventilation), were enrolled. The patients were administered with a combination of iNO therapy at 20 ppm while in the supine position (SP) and prone position (PP). Various clinical variables were collected at baseline in the SP, as well as at 4 and 12-h during PP, and after 30-60 min of iNO treatment (SP, SP + iNO, PP, PP + iNO). The pulmonary ventilation-perfusion status, such as the global inhomogeneity (GI) index of ventilation and perfusion, dead space fraction, intrapulmonary shunt fraction, and V/Q matching was monitored using electrical impedance tomography (EIT). Additionally, respiratory mechanics, gas exchange, and hemodynamic parameters were recorded. RESULTS: A total of 24 patients with severe ARDS were enrolled, including 17 males and 7 females. The mean oxygenation index PaO CONCLUSION: In patients with moderate-to-severe ARDS, both iNO and PP are beneficial for improving V/Q matching and oxygenation. However, no combined effect of iNO and PP was observed.

3. Physiology-guided management of patients with severe hypoxemia ineligible for ECMO: a multidisciplinary lung rescue team approach.

59.5Level IIICohort
Critical care (London, England) · 2025PMID: 41272741

In ECMO-ineligible patients with severe hypoxemia, a multidisciplinary Lung Rescue Team using advanced physiological tools prompted management changes in 82.3% of cases, with notable 90-day (48.3%) and 1-year (44.8%) survival. The findings support systematic re-evaluation instead of early palliation in this often-neglected population.

Impact: It operationalizes a physiology-first, multidisciplinary framework for an underrepresented, high-mortality group, demonstrating feasible implementation and meaningful survival.

Clinical Implications: Consider deploying a multidisciplinary, physiology-guided consult pathway (e.g., EIT- or transpulmonary pressure-informed PEEP) before declaring futility in severe hypoxemia not eligible for ECMO.

Key Findings

  • LRT consultation resulted in respiratory management changes in 82.3% of patients, commonly via EIT- or transpulmonary pressure-guided PEEP adjustments.
  • Survival was 48.3% at 90 days and 44.8% at 1 year despite ECMO ineligibility and refractory hypoxemia.
  • Most deaths were due to multiorgan failure (50%), followed by hypoxemia (25%) and unresponsive shock (25%).

Methodological Strengths

  • Multidisciplinary, physiology-guided framework with advanced tools (EIT, transpulmonary pressure) applied in real time
  • Focus on an underreported, high-risk population typically excluded from trials

Limitations

  • Single-center, retrospective design without a control group limits causal inference
  • Potential selection bias and unspecified sample size in the abstract

Future Directions: Prospective, multicenter evaluation of Lung Rescue Team workflows, standardized decision algorithms, and comparative effectiveness versus usual care.

BACKGROUND: ARDS affects a significant proportion of ventilated ICU patients and carries high mortality, especially in cases of severe hypoxemia unresponsive to standard treatments and ineligible for extracorporeal membrane oxygenation (ECMO). In such situations, care often shifts to comfort measures due to limited data and structured guidance. To address this gap, Massachusetts General Hospital established the Lung Rescue Team (LRT), a multidisciplinary group using advanced physiological tools to provide individualized, real-time management beyond protocolized care. OBJECTIVE: To evaluate the feasibility and application of a complex, physiology-guided framework in patients with severe hypoxemia who had not responded to standard or advanced interventions and were ineligible for rescue therapies such as ECMO, population typically excluded from clinical trials and often regarded as beyond curative treatment. DESIGN: This single-center, retrospective observational study included adult patients in the intensive care unit (ICU ( RESULTS: LRT consultation led to changes in respiratory management in 82.3% of patients who had already attend to receive maximal therapy, most commonly adjustments to PEEP based on EIT or transpulmonary pressure. The median ICU length of stay was 18.5 days (IQR 10.5–31.5). Survival was 48.3% at 90 days and 44.8% at 1 year. The leading cause of death was multiorgan failure (50%), followed by hypoxemia (25%) and unresponsive shock (25%). CONCLUSIONS: This study describes the experience of a physiology-guided, multidisciplinary LRT in patients with severe hypoxemia ineligible for ECMO, individuals often excluded from clinical trials and frequently considered beyond curative treatment. Survival in this cohort was far from negligible, highlighting the value of systematic re-evaluation rather than premature transition to palliation. Although causal inferences cannot be drawn from this retrospective, single-center analysis, the findings provide insight into an underreported population and generate hypotheses for future prospective studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-025-05709-9.